FY18
Assets20.52
Net Worth4.21
Total Debt7.22
RevenueAnnualised basis35.43
EBITDAAnnualised basis1.46
PATAnnualised basis0.85
EBITDA Margin (%)4.12
At a glance
Updated 2026-09-06Earum Pharmaceuticals is an IPO with an issue size of ₹6.65 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹6.65 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets27.41₹ Cr · +212.2% vs prior year
Net Worth5.07₹ Cr · +272.8% vs prior year
FY17
Assets11.08
Net Worth1.52
Total Debt2.08
RevenueAnnualised basis23.33
EBITDAAnnualised basis0.31
PATAnnualised basis0.15
EBITDA Margin (%)1.33
FY16
Assets8.78
Net Worth1.36
Total Debt1.89
RevenueAnnualised basis18.56
EBITDAAnnualised basis0.47
PATAnnualised basis0.09
EBITDA Margin (%)2.53
31-Dec-18
Assets27.41
Net Worth5.07
Total Debt7.89
RevenueAnnualised basis34.49
EBITDAAnnualised basis1.92
PATAnnualised basis0.86
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Earum Pharmaceuticals IPO | — | 19.00 x | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-06.
IPO UPDATE ALERTS
Register for IPO Updates →Track Earum Pharmaceuticals without missing an update
Register for subscription, GMP, allotment and listing notifications.